Companies / Janux Therapeutics, Inc. / Activity
Activity — Janux Therapeutics, Inc.
3 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Campbell David Alan CEO | Sell | Common Stock | $110.8K | -8K -2.75% | 284,982 0.47% of shares | medium |
| Jan 2, 2026 | Campbell David Alan CEO | Grant | Common Stock | $0 | +97K +33.90% | 381,582 0.62% of shares | low |
| Jan 2, 2026 | Campbell David Alan CEO | Grant | Stock option (right to buy) | — | +338K | 338,100 0.55% of shares | low |